Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Ayman, Samkari"'
Autor:
Takaaki Tokito, Oleksii Kolesnik, Jens Sørensen, Mehmet Artac, Martín Lázaro Quintela, Jong-Seok Lee, Maen Hussein, Miklos Pless, Luis Paz-Ares, Lance Leopold, Jeannie Daniel, Mihaela Munteanu, Ayman Samkari, Lu Xu, Charles Butts
Publikováno v:
BMC Cancer, Vol 23, Iss S1, Pp 1-11 (2024)
Abstract Background Pembrolizumab is a first-line therapy for certain patients with advanced/metastatic non-small cell lung cancer (NSCLC). Combining pembrolizumab with other immunotherapies may enhance tumor cell killing and clinical outcomes. Epaca
Externí odkaz:
https://doaj.org/article/778d9a0bf7f040a3adf76b4a236aef6f
Autor:
Michael Boyer, Rina Hui, Damien Urban, Philip Clingan, Wu-Chou Su, Celine Devaux, Shirish Gadgeel, Marina Garassino, Lance Leopold, Jeannie Daniel, Mihaela C. Munteanu, Ayman Samkari, Yiwen Luo, Delvys Rodriguez Abreu
Publikováno v:
BMC Cancer, Vol 23, Iss S1, Pp 1-12 (2024)
Abstract Background The combination of the checkpoint inhibitor (CPI) pembrolizumab and platinum-based chemotherapy is effective frontline therapy for advanced non-small cell lung cancer (NSCLC) lacking targetable mutations. Indoleamine 2,3- dioxygen
Externí odkaz:
https://doaj.org/article/f859d06395444ff68173b8d586898c31
Autor:
Xiaohan Hu, Diana Chirovsky, Mark S. Walker, Yuexi Wang, Alpana Kaushiva, Jon Tepsick, Ayman Samkari
Publikováno v:
BMC Pulmonary Medicine, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Real-world data regarding patient characteristics, adjuvant treatment patterns, and long-term survival outcomes are needed to better understand unmet needs among patients with completely resected early-stage non-small cell lung ca
Externí odkaz:
https://doaj.org/article/43a5e59b84124717bc48abca3c4b638a
Autor:
Paul Williams, MPH, Thomas Burke, PharmD, PhD, Josephine M. Norquist, MS, Christina Daskalopoulou, PhD, Rebecca M. Speck, PhD, MPH, Ayman Samkari, MD, Sonya Eremenco, MA, Stephen Joel Coons, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 4, Pp 100298- (2022)
Introduction: The NSCLC Symptom Assessment Questionnaire (NSCLC-SAQ) was developed to assess NSCLC symptom severity in accordance with Food and Drug Administration evidentiary expectations leading to Food and Drug Administration qualification in 2018
Externí odkaz:
https://doaj.org/article/8d468e1a5b034839bcd5b307bedd8363
Autor:
Aaron S. Mansfield, MD, Roy S. Herbst, MD, PhD, Gilberto de Castro, Jr., MD, PhD, Rina Hui, MB, BS, PhD, Nir Peled, MD, PhD, Dong-Wan Kim, MD, Silvia Novello, MD, PhD, Miyako Satouchi, MD, Yi-Long Wu, MD, Edward B. Garon, MD, Martin Reck, MD, PhD, Andrew G. Robinson, MD, Ayman Samkari, MD, Bilal Piperdi, MD, Victoria Ebiana, MD, Jianxin Lin, MS, Tony S.K. Mok, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 8, Pp 100205- (2021)
Introduction: We retrospectively evaluated outcomes in patients with programmed death-ligand 1 (PD-L1)–positive non–small-cell lung cancer (NSCLC) to determine whether baseline (i.e., at study enrollment) brain metastases were associated with the
Externí odkaz:
https://doaj.org/article/4253c840bb3a4ea2a990a5ad8dd55f52
Autor:
Howard West, Xiaohan Hu, Su Zhang, Yan Song, Diana Chirovsky, Chi Gao, Ariel Lerner, Anya Jiang, James Signorovitch, Ayman Samkari
Publikováno v:
Clinical Lung Cancer. 24:260-268
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6d78c1aa3841fc5adddaa509d2c6fe8
https://doi.org/10.1016/j.cllc.2022.12.005
https://doi.org/10.1016/j.cllc.2022.12.005
Autor:
Mary O’Brien, Luis Paz-Ares, Sandrine Marreaud, Urania Dafni, Kersti Oselin, Libor Havel, Emilio Esteban, Dolores Isla, Alex Martinez-Marti, Martin Faehling, Masahiro Tsuboi, Jong-Seok Lee, Kazuhiko Nakagawa, Jing Yang, Ayman Samkari, Steven M Keller, Murielle Mauer, Nitish Jha, Rolf Stahel, Benjamin Besse, Solange Peters
Publikováno v:
The Lancet Oncology. 23:1274-1286
Pembrolizumab is a standard-of-care for advanced non-small-cell lung cancer (NSCLC). We assessed pembrolizumab as adjuvant therapy for completely resected stage IB-IIIA NSCLC.In this randomised, triple-blind, phase 3 trial (PEARLS/KEYNOTE-091), patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::546d56085895273ebf924ed87a7e4b0b
https://doi.org/10.1016/s1470-2045(22)00518-6
https://doi.org/10.1016/s1470-2045(22)00518-6
Autor:
Howard West, Xiaohan Hu, Diana Chirovsky, Mark S Walker, Yuexi Wang, Alpana Kaushiva, Jon Tepsick, Ayman Samkari
Publikováno v:
Future Oncology.
Aim: Real-world data on outcomes for early-stage non-small-cell lung cancer (NSCLC) are needed to better understand the benefits of new therapies. Methods: In this retrospective study using the ConcertAI Patient360™ database, overall survival and h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96aa4a08a488e05cbb59f8b9c801af6c
https://doi.org/10.2217/fon-2023-0024
https://doi.org/10.2217/fon-2023-0024
Autor:
Yuting Kuang, Christine M. Pierce, Hsiu-Ching Chang, Alexandra Z. Sosinsky, Anne C. Deitz, Steven M. Keller, Ayman Samkari, Jennifer Uyei
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 174
High-grade pneumonitis is a severe and potentially life-threatening adverse event associated with concurrent chemoradiation (cCRT) in patients with non-small cell lung cancer (NSCLC). The aim of this study was to summarize and quantify the incidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7375ee83879e70c3bf15cab8e2d9108b
https://pubmed.ncbi.nlm.nih.gov/35717343
https://pubmed.ncbi.nlm.nih.gov/35717343
Autor:
Lauren Weaver, Ayman Samkari
Publikováno v:
Seminars in Pediatric Neurology. 24:60-69
Though the treatment of pediatric cancers has come a long way, acute and chronic effects of cancer are still affecting the life of many children. These effects may be caused not only by the malignancy itself but also by the interventions used for the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee03472c04a69df95894082b031e88b5
https://doi.org/10.1016/j.spen.2016.12.005
https://doi.org/10.1016/j.spen.2016.12.005